Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 134 |
|---|
Dr. Matthew Boland Yurgelun, MD, FASCO is a medical oncologist in BOSTON, MA specializing in medical oncology and adult oncology. He graduated from Columbia University, College of Physicians and Surgeons. Dr. Matthew Boland Yurgelun, MD, FASCO is affiliated with Dana-Farber Cancer Institute and DANA-FARBER CANCER INSTITUTE, INC.
Gastrointestinal Problems (Digestive Disorders)
The gastrointestinal system, or GI tract, is the name given to a collection of organs that work together to digest food. These organs fit together in a long tube, running from the mouth to the anus, and include the esophagus, stomach, and intestines, among others. With so many parts working together, complicated by today's busy lifestyles and diets, digestive problems are common. As many as 1 in 3 Americans have a digestive or GI disorder. There are a huge variety of digestive problems, but the most common are IBS, constipation, GERD, hemorrhoids, and ulcers.
IBS, or irritable bowel syndrome, happens when the muscles surrounding the colon contract too easily or frequently. The result is abdominal pain, cramps, diarrhea or constipation, gas and bloating. IBS attacks can often be brought on by specific triggers, so a key part of treatment is learning which foods trigger IBS attacks and avoiding them. Treatment also includes exercise, avoiding stress, and medications if needed.
Constipation, or large, hard, or infrequent stools, happens to everyone at some point. It can be caused by a disruption in routine or food, or by eating a diet without many fresh fruits and vegetables. Although it is uncomfortable, constipation is common and usually not serious, but it can sometimes become chronic. Adding fiber to the diet, exercising, and taking medications may help.
GERD, or gastroesophageal reflux disease, is a severe form of chronic heartburn where stomach acid spills back up into the esophagus. Left untreated, the acid may even eat away at the esophagus and cause serious damage. Treatment includes changing the diet to avoid trigger foods, losing weight if needed, medications, or even surgery.
Hemorrhoids are blood vessels around the rectum that become irritated, swollen or torn while straining during a bowel movement. They are most often caused by constipation, but can also be caused by pregnancy, diarrhea, or simply a genetic predisposition towards hemorrhoids. Treatment involves first treating any constipation issues, then keeping the area clean and soothed until it has healed. If these measures are ineffective, surgery is sometimes used.
Peptic ulcers are sores or spots of inflammation in the lining of the stomach or close to the stomach in the small intestine. Usually this area is coated with a protective lining that shields the tissue from the strong stomach acid, but a break in the lining can let acid in, causing the sores. It used to be thought that stress caused ulcers, but now it is known that is not the case. Most often, they are caused by an infection by H. pylori bacteria, but ulcers can also be caused by alcohol abuse or overuse of aspirin, ibuprofen, naproxen, or other NSAIDS. The symptoms of an ulcer are pain, hunger, nausea, and fatigue.
Gastrointestinal problems, perhaps more than any other area, are markedly affected by lifestyle. Many disorders can be prevented or treated at least in part by eating a healthy diet high in fiber, exercising regularly, drinking enough water, and limiting alcohol intake. Still, the frequency of digestive disorders means that even the healthiest person can be affected by them. Anyone who notices blood in their stool, experiences abdominal pain, unexplained weight loss, or any significant change in bowel movements should see a doctor.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 134 |
|---|
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2013 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 337 |
|---|---|
| hospital care | 136 |
| inpatient care | 136 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 83 |
|---|---|
| Female | 75 |
| Non-Hispanic White | 131 |
|---|---|
| Black | 0 |
| Hispanic | 11 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 75 |
|---|---|
| From 75 to 84 | 47 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 54 |
| Stroke | 0 |
| Ischemic Heart Disease | 37 |
| Depression | 30 |
| Chronic Kidney Disease | 37 |
| Asthma | 8 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 11 |
| Heart Failure | 22 |
| Chronic Obstructive Pulmonary Disease | 15 |
| Diabetes | 35 |
| Dementia | 0 |
| Cancer | 49 |
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2014 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 329 |
|---|---|
| hospital care | 145 |
| inpatient care | 145 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 83 |
|---|---|
| Female | 60 |
| Non-Hispanic White | 113 |
|---|---|
| Black | 0 |
| Hispanic | 14 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 76 |
|---|---|
| From 75 to 84 | 41 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 52 |
| Stroke | 0 |
| Ischemic Heart Disease | 38 |
| Depression | 31 |
| Chronic Kidney Disease | 30 |
| Asthma | 10 |
| Osteoperosis | 8 |
| Atrial Fibrilation | 15 |
| Heart Failure | 17 |
| Chronic Obstructive Pulmonary Disease | 13 |
| Diabetes | 34 |
| Dementia | 8 |
| Cancer | 51 |
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2015 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 378 |
|---|---|
| hospital care | 94 |
| inpatient care | 94 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 180 |
|---|---|
| Female | 138 |
| Non-Hispanic White | 256 |
|---|---|
| Black | 0 |
| Hispanic | 24 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 168 |
|---|---|
| From 75 to 84 | 68 |
| 85 and over | 22 |
| Less than 65 | 60 |
| Hypertension | 66 |
|---|---|
| High Cholesterol | 52 |
| Stroke | 9 |
| Ischemic Heart Disease | 33 |
| Depression | 28 |
| Chronic Kidney Disease | 31 |
| Asthma | 13 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 14 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 14 |
| Diabetes | 30 |
| Dementia | 0 |
| Cancer | 53 |
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2016 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 333 |
|---|---|
| hospital care | 47 |
| inpatient care | 47 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 82 |
|---|---|
| Female | 76 |
| Non-Hispanic White | 138 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 94 |
|---|---|
| From 75 to 84 | 37 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 70 |
|---|---|
| High Cholesterol | 55 |
| Stroke | 7 |
| Ischemic Heart Disease | 36 |
| Depression | 29 |
| Chronic Kidney Disease | 37 |
| Asthma | 13 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 11 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 11 |
| Diabetes | 30 |
| Dementia | 8 |
| Cancer | 47 |
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2017 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 371 |
|---|---|
| hospital care | 72 |
| inpatient care | 72 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 89 |
|---|---|
| Female | 86 |
| Non-Hispanic White | 152 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 94 |
|---|---|
| From 75 to 84 | 49 |
| 85 and over | 13 |
| Less than 65 | 19 |
| Hypertension | 70 |
|---|---|
| High Cholesterol | 49 |
| Stroke | 0 |
| Ischemic Heart Disease | 37 |
| Depression | 29 |
| Chronic Kidney Disease | 39 |
| Asthma | 9 |
| Osteoperosis | 12 |
| Atrial Fibrilation | 9 |
| Heart Failure | 14 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 26 |
| Dementia | 13 |
| Cancer | 50 |
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 406 |
|---|
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 88 |
|---|---|
| Female | 107 |
| Non-Hispanic White | 174 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 106 |
|---|---|
| From 75 to 84 | 55 |
| 85 and over | 11 |
| Less than 65 | 23 |
| Hypertension | 61 |
|---|---|
| High Cholesterol | 59 |
| Stroke | 8 |
| Ischemic Heart Disease | 40 |
| Depression | 27 |
| Chronic Kidney Disease | 34 |
| Asthma | 0 |
| Osteoperosis | 12 |
| Atrial Fibrilation | 9 |
| Heart Failure | 12 |
| Chronic Obstructive Pulmonary Disease | 14 |
| Diabetes | 32 |
| Dementia | 12 |
| Cancer | 42 |
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 466 |
|---|
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 98 |
|---|---|
| Female | 101 |
| Non-Hispanic White | 179 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 114 |
|---|---|
| From 75 to 84 | 61 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 63 |
|---|---|
| High Cholesterol | 60 |
| Stroke | 6 |
| Ischemic Heart Disease | 37 |
| Depression | 31 |
| Chronic Kidney Disease | 35 |
| Asthma | 8 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 11 |
| Heart Failure | 10 |
| Chronic Obstructive Pulmonary Disease | 13 |
| Diabetes | 28 |
| Dementia | 10 |
| Cancer | 36 |
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2020 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 324 |
|---|---|
| hospital care | 56 |
| inpatient care | 56 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 109 |
|---|---|
| Female | 122 |
| Non-Hispanic White | 197 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 13 |
| Native American | 0 |
| From 65 to 74 | 141 |
|---|---|
| From 75 to 84 | 60 |
| 85 and over | 13 |
| Less than 65 | 17 |
| Hypertension | 66 |
|---|---|
| High Cholesterol | 56 |
| Stroke | 0 |
| Ischemic Heart Disease | 38 |
| Depression | 29 |
| Chronic Kidney Disease | 39 |
| Asthma | 6 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 10 |
| Heart Failure | 15 |
| Chronic Obstructive Pulmonary Disease | 7 |
| Diabetes | 27 |
| Dementia | 8 |
| Cancer | 42 |
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 320 |
|---|
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 100 |
|---|---|
| Female | 117 |
| Non-Hispanic White | 182 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 16 |
| Native American | 0 |
| From 65 to 74 | 136 |
|---|---|
| From 75 to 84 | 55 |
| 85 and over | 11 |
| Less than 65 | 15 |
| Hypertension | 57 |
|---|---|
| High Cholesterol | 56 |
| Stroke | 6 |
| Ischemic Heart Disease | 35 |
| Depression | 23 |
| Chronic Kidney Disease | 34 |
| Asthma | 6 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 8 |
| Heart Failure | 9 |
| Chronic Obstructive Pulmonary Disease | 5 |
| Diabetes | 31 |
| Dementia | 8 |
| Cancer | 41 |
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2022 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 255 |
|---|---|
| hospital care | 70 |
| inpatient care | 70 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 88 |
|---|---|
| Female | 118 |
| Non-Hispanic White | 175 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 17 |
| Native American | 0 |
| From 65 to 74 | 117 |
|---|---|
| From 75 to 84 | 61 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 66 |
|---|---|
| High Cholesterol | 69 |
| Stroke | 8 |
| Ischemic Heart Disease | 24 |
| Depression | 25 |
| Chronic Kidney Disease | 18 |
| Asthma | 15 |
| Osteoperosis | 17 |
| Atrial Fibrilation | 12 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 11 |
| Diabetes | 24 |
| Dementia | 0 |
| Cancer | 57 |
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 288 |
|---|
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 78 |
|---|---|
| Female | 108 |
| Non-Hispanic White | 165 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 106 |
|---|---|
| From 75 to 84 | 54 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 65 |
|---|---|
| High Cholesterol | 71 |
| Stroke | 6 |
| Ischemic Heart Disease | 23 |
| Depression | 24 |
| Chronic Kidney Disease | 15 |
| Asthma | 11 |
| Osteoperosis | 19 |
| Atrial Fibrilation | 15 |
| Heart Failure | 11 |
| Chronic Obstructive Pulmonary Disease | 9 |
| Diabetes | 19 |
| Dementia | 0 |
| Cancer | 50 |
The top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA during 2024 were hospital care and inpatient care.
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
| doctor visit | 291 |
|---|---|
| hospital care | 67 |
| inpatient care | 67 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 77 |
|---|---|
| Female | 120 |
| Non-Hispanic White | 165 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 18 |
| Native American | 0 |
| From 65 to 74 | 115 |
|---|---|
| From 75 to 84 | 57 |
| 85 and over | 13 |
| Less than 65 | 12 |
| Hypertension | 66 |
|---|---|
| High Cholesterol | 70 |
| Stroke | 7 |
| Ischemic Heart Disease | 27 |
| Depression | 29 |
| Chronic Kidney Disease | 21 |
| Asthma | 14 |
| Osteoperosis | 22 |
| Atrial Fibrilation | 19 |
| Heart Failure | 18 |
| Chronic Obstructive Pulmonary Disease | 12 |
| Diabetes | 24 |
| Dementia | 7 |
| Cancer | 55 |
Volume of procedures performed by Dr. Matthew Boland Yurgelun, MD, FASCO for Medicare patients.
The highest averages for the top procedures that Dr. Matthew Boland Yurgelun, MD, FASCO treated as a medical oncologist in BOSTON, MA were hospital care and inpatient care.
| doctor visit | 325 |
|---|---|
| hospital care | 85 |
| inpatient care | 85 |
Information about Medicare patients treated by Dr. Matthew Boland Yurgelun, MD, FASCO.
| Male | 88 |
|---|---|
| Female | 94 |
| Black / African American | 0 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 155 |
| Hispanic | 3 |
| Native American / Alaskan Native | 0 |
| Other | 4 |
| 75 to 84 | 49 |
|---|---|
| 85 and over | 6 |
| Less than 65 | 11 |
| 65 to 74 | 103 |
The highest averages of the most common conditions of Medicare patients that Dr. Matthew Boland Yurgelun, MD, FASCO treated were hypertension, high cholesterol, cancer and ischemic heart disease.
| Hypertension | 61 |
|---|---|
| High Cholesterol | 54 |
| Stroke | 4 |
| Ischemic Heart Disease | 31 |
| Depression | 25 |
| Chronic Kidney Disease | 28 |
| Asthma | 8 |
| Osteoporosis | 10 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 26 |
| Atrial Fibrillation | 11 |
| Cancer | 44 |
| Dementia | 5 |
Dr. Matthew Boland Yurgelun, MD, FASCO graduated from Columbia University, College of Physicians and Surgeons. He completed residency at Beth Israel Deaconess Medical Center. He is certified by the Board Certification:Medical Oncology and has a state license in Massachusetts.
Medical School: Columbia University, College of Physicians and Surgeons
Residency: Beth Israel Deaconess Medical Center
Board Certification: Board Certification:Medical Oncology
Licensed In: Massachusetts
Dr. Matthew Boland Yurgelun, MD, FASCO has an exceptional overall rating with an average of 5.0 out of 5 stars based on 97 ratings. We collect ratings and reviews of Dr. Matthew Boland Yurgelun, MD, FASCO from all over the web to help you find the right in BOSTON, MA.
These charts describe general payments received by Dr. Matthew Boland Yurgelun, MD, FASCO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| AstraZeneca Pharmaceuticals LP |
$43
Enhertu $43 |
|---|
| Education | $43 |
|---|
Dr. Matthew Boland Yurgelun, MD, FASCO has received 15 research payments totaling $38,425.
Dr. Matthew Yurgelun practices adult oncology and medical oncology. He has a 5.0 out of 5 star average patient rating. His areas of expertise include the following: esophageal cancer, rectal cancer, and colon cancer. Dr. Yurgelun is professionally affiliated with Dana-Farber Cancer Institute. According to Doctor.com, new patients are welcome to contact his office in BOSTON, MA. Dr. Yurgelun attended Columbia University, College of Physicians and Surgeons for medical school and subsequently trained at Beth Israel Deaconess Medical Center for residency. Awards and/or distinctions he has received include Fellow of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGAF) and Fellow of the American Society of Clinical Oncology (FASCO).